Upper GI 2016

POST-OPERATIVE treatments fail to improve OS

N population experimental

mOS (months)

3-year Survival (%)

Zieren, 1995

68

100% SCC

Surg +/- RT

NR

20 vs 22

Fok, 1993

130

80% SCC 20% ADC

Surg +/- RT

15.2 vs 8.7

NR

Teniere, 1991

221 100% SCC

Surg +/- RT

18 vs 18

17.6 vs 18.6 (5yrs)

Xiao, 2003

495 100% SCC

Surg +/- RT

NR

31.7 vs 41.3 (5yrs)

Ando, 2003

242 100% SCC

Surg +/- CT

NR

52 vs 61 (5yrs)

MacDonald, 2005

556 80% adc gastr 20% adc oeso

Surg +/- RTCT

27 vs 36

41 vs 50

✔